Antares Pharma, Inc. (ATRS)

[jab91252]

Among the fine responses by tdpeterson, shadow, ryman and bio pete below I'll post directly from CEO Paul Wotton during the RBC Healthcare conference the other month:

"The thing to remember here is that MTX is an already approved drug and the challenge here was being able to convert an approved drug that’s given by intramuscular injection which usually requires a professional to administer it – converting it to an easy to use subcutaneous route of administration which can be given at home. So we switched the route. We will be the first company to have a subcutaneous route approval for MTX and that’s really the opportunity and all the work we did in the studies supported that conclusion."

jab9